DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Yang JC, Haworth L, Sherry RM et al.
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.
N Engl J Med 2003;
349: 427-434
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.